Whitepapers

Sponsored Content

Tumor-infiltrating lymphocytes may hold the key to treating solid tumors with cell therapies, and BioIVT’s DTC product line is a great source for TILs. In this white paper, you’ll read about defining what TILs are, their potential therapeutic applications, the characterization of BioIVT’s current donor pool by TIL content and the frequency of TILs by tumor tissue type.

Sponsored Content

When isolating peripheral blood mononuclear cells (PBMCs) from whole blood, red blood cell (RBC) contamination can have a significant impact on your downstream results. In this white paper, learn the sources of RBC contamination, the downstream impact of RBC contamination and mitigation strategies that will improve your results.

Sponsored Content

This article will discuss pharmaceutical package testing specifically Helium leak detection technology and how it solves cold supply chain challenges of today’s high-risk pharmaceutical products.  This article also addresses the importance of phase appropriate leak testing from manufacturing through product lifecycle.

Sponsored Content

Explore single-use bag system technologies for freeze/thaw applications in bulk drug substance (BDS) manufacturing. Transitioning to SUT can be an efficient, cost-effective option for biopharmaceutical manufacturers to hit performance targets.

Sponsored Content

Used by leading pharma companies and CDMOs, the Beacon system offers an integrated end-to-end automated workflow for mammalian cell line development. Clones can be selectively enriched for unique phenotypes and multiple assays can be used to rapidly measure productivity of different antibody molecules.

The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022. It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizations (CMOs) to support.